High-Throughput Ex Vivo Drug Sensitivity and Resistance Testing (DSRT) Integrated with Deep Genomic and Molecular Profiling Reveal New Therapy Options with Targeted Drugs in Subgroups of Relapsed Chemorefractory AML

: Heckman CA, Kontro M, Pemovska T, Eldfors S, Edgren H, Kulesskiy E, Majumder MM, Karjalainen R, Yadav B, Szwajda A, Venkata NPK, Murumagi A, Malani D, Parsons A, Hintsanen P, Almusa H, Marti JML, Ellonen P, Mattila P, Lepisto M, Lagstrom S, Suvela M, Mustjoki S, Saarela J, Aittokallio T, Kallioniemi O, Wennerberg K, Porkka K

Publisher: AMER SOC HEMATOLOGY

: 2012

Blood

BLOOD

: BLOOD

: 120

: 21

: 2

: 0006-4971

DOI: https://doi.org/10.1182/blood.V120.21.288.288